| Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells MN Tran, T Medveczki, B Besztercei, G Torok, AJ Szabo, X Gasull, ... Life 13 (7), 1581, 2023 | 2 | 2023 |
| Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells J Hodrea, MN Tran, B Besztercei, T Medveczki, AJ Szabo, L Orfi, I Kovacs, ... International Journal of Molecular Sciences 24 (14), 11646, 2023 | 1 | 2023 |
| Fluvoxamine supresses transforming growth factor beta‐2‐induced fibrotic changes in trabecular meshwork cells T Medveczki, MN Tran, B Besztercei, G Torok, I Kovacs, AJ Szabo, ... Acta Ophthalmologica 102, 2024 | | 2024 |
| Sigma-1 receptor agonist ameliorates trabecular meshwork fibrosis by modulating extracellular matrix remodeling and increasing nitric oxide production J Hodrea, MN Tran, B Besztercei, T Medveczki, I Kovacs, X Gasull, ... Investigative Ophthalmology & Visual Science 64 (8), 3450-3450, 2023 | | 2023 |
| Sigma− 1 receptor activation as a new option for the treatment of glaucoma in preclinical models A Fekete, MN Tran, B Besztercei, G Torok, T Medveczki, A Takácsi‐Nagy, ... Acta Ophthalmologica 100, 2022 | | 2022 |
